Trial intelligence / Profile preview

Enteral midodrine for vasopressor weaning in septic shock

PACTR202605704602241Phase 3Recruiting

Sponsor
Menoufia University Hospitals
Start
Jan 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of midodrine, sponsored by Menoufia University Hospitals. Started Jan 2026; status: recruiting.

02

Drugs

midodrine

Beyond the preview

Go deeper on PACTR202605704602241.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202605704602241.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call